Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Schizophrenic
92%
Schizophrenia
74%
Electroconvulsive Therapy
27%
Obsessive-compulsive Disorder
24%
Comorbid
22%
Akathisia
21%
Olanzapine
20%
Corneal Temperature
20%
Trazodone
20%
Benign Paroxysmal Positional Vertigo
20%
Patients with Schizophrenia
20%
Psychosis
15%
Selective Serotonin Reuptake Inhibitors
15%
Randomized Placebo-controlled Trial
15%
Amantadine
14%
Mental Status
14%
Negative Syndrome
14%
Treatment-resistant Schizophrenia
13%
Augmentation Therapy
13%
Escitalopram
13%
Clozapine
13%
Dehydroepiandrosterone
13%
Donepezil
13%
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
13%
Negative Symptoms
12%
Placebo
11%
Antipsychotic Drugs
11%
Drug-free
11%
Psychotic
10%
Psychotic Patients
10%
Violence
9%
Obsessive-compulsive
9%
Obsessive-compulsive Symptoms
9%
Israel
9%
DSM-IV
9%
Aggression
9%
Psychiatric Disorders
9%
Depressive Symptoms
8%
Monotherapy
8%
Treatment-resistant Depression
8%
Psychiatrists
8%
Extrapyramidal Symptoms
8%
Placebo-controlled
8%
Psychiatric Ward
8%
Dizziness
8%
Violent Behavior
7%
Blood Pressure
7%
Cannabis
7%
Beneficial Effects
7%
High Dose
7%
Neuroscience
Schizophrenia
100%
Electroconvulsive Therapy
27%
Negative Syndrome
19%
Psychopathology
15%
Positive Syndrome
15%
Obsessive-Compulsive Disorder
14%
Placebo
14%
Mental Disorder
13%
Treatment-Resistant Schizophrenia
13%
Donepezil
13%
Dehydroepiandrosterone
13%
Olanzapine
13%
Psychosis
13%
Antipsychotic
12%
Behavior (Neuroscience)
12%
Blood Plasma
8%
Major Depressive Disorder
7%
Amantadine
7%
Selective Serotonin Reuptake Inhibitor
6%
Platelet
6%
Trazodone
6%
Clozapine
6%
Crossover Study
6%
Escitalopram
6%
Serotonin Reuptake Inhibitor
6%
Extrapyramidal Symptoms
6%
Vesicular Monoamine Transporter
6%
Chromosome 10p
6%
Chloral Hydrate
6%
Phosphatidylinositide
6%
In Vivo
6%
Treatment-Resistant Depression
6%
Magnetic Resonance Imaging of Brain
6%
Brain Imaging
6%
Brainstem
6%
Creatine Kinase
6%
Benign Paroxysmal Positional Vertigo
6%
Transcranial Magnetic Stimulation
6%
Mood Disorder
6%
Vesicular Monoamine Transporter 2
6%
Longitudinal Study
6%
Cannabinoid
6%
Otolith
6%
Rivastigmine
6%
Nuclear Magnetic Resonance Spectroscopy
6%
Social Anxiety Disorder
6%
Haloperidol
6%
Zuclopenthixol
6%
Acetate
6%
Vestibular Evoked Myogenic Potential
6%
Medicine and Dentistry
Schizophrenia
76%
Obsessive Compulsive Disorder
18%
Clozapine
13%
Escitalopram
13%
Electroconvulsive Therapy
13%
Yale-Brown Obsessive Compulsive Scale
13%
Vertigo
10%
Selective Serotonin Reuptake Inhibitor
9%
Prevalence
9%
Self Report
9%
Cross Sectional Study
8%
Prospective Study
8%
Positive and Negative Syndrome Scale
8%
Monotherapy
7%
Drug Megadose
7%
DSM-IV
7%
Dizziness
7%
Vesicular Monoamine Transporter
6%
Attention Deficit Disorder
6%
Drug Use
6%
Donepezil
6%
Selegiline
6%
Positional Vertigo
6%
Cannabis Use
6%
Prasterone
6%
Mean Platelet Volume
6%
Levodopa
6%
Platelet
6%
Blood Pressure
6%
Noradrenalin
6%
Lymphocyte
6%
Parkinson's Disease
6%
Vesicular Monoamine Transporter 2
6%
Thermoregulation
6%
Psychiatrist
6%
Neutrophil
6%
QT Dispersion
6%
Social Phobia
6%
Vestibular Evoked Myogenic Potential
6%
Amantadine
6%
Systemic Lupus Erythematosus
6%
Brainstem
6%
Inflammation
6%
Major Depressive Episode
6%
Endocannabinoid
6%
Diseases
6%
